We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoparticle Breakthrough Leads to Highly Accurate Pregnancy Tests

By LabMedica International staff writers
Posted on 07 Nov 2011
Extremely accurate pregnancy tests could be created by precisely measuring specific nanoparticle cluster-size agglomeration and the resulting characteristic light absorption.

Researchers at the US National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) developed the new technique by coating gold nanoparticles with antibodies to human chorionic gonadotropin (hCG), a hormone produced by an embryo following conception. More...
The researchers first prepared samples of gold nanoparticles with a controlled distribution of sizes; they were then allowed to agglomerate in gradually growing clusters. The clumping process was then deactivated after varying lengths of time by adding a stabilizing agent, preventing further agglomeration.

Since only certain size clusters are optimal for this technique, analytical ultracentrifugation (AUC) was used to simultaneously sort the clusters by size and measure their light absorption. AUC causes the nanoparticle clusters to separate by size, the smaller, lighter clusters moving more slowly than the larger ones. While this is happening, the sample containers are repeatedly scanned with light and the amount of light passing through the sample for each color frequency is recorded; the larger the cluster, the more light is absorbed by lower frequencies. Measuring the absorption by frequency across the sample containers allowed the researchers both to watch the gradual separation of cluster sizes and to correlate absorbed frequencies with specific cluster sizes. The study was published on September 3, 2011, in ACS Nano.

“Most previous measurements of absorption spectra for solutions of nanoparticles were able only to measure the bulk spectra - the absorption of all the different cluster sizes mixed together,” said lead author biomedical engineer Justin Zook, PhD, of the NIST. “AUC makes it possible to measure the quantity and distribution of each nanoparticle cluster without being confounded by other components in complex biological mixtures, such as proteins.”

Related Links:
US National Institute of Standards and Technology


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.